This comprehensive report examines personalized medicine, an evolving healthcare approach that tailors treatments to an individual's unique biological makeup, contrasting it with traditional "one-size-fits-all" methods. It explains how biotechnologies like genomics, proteomics, and pharmacogenomics provide the necessary molecular data, which is then analyzed using bioinformatics and artificial intelligence to generate actionable insights. The document highlights successful clinical applications in oncology, immunology, and rare genetic disorders, showcasing how biomarker-driven therapies and gene editing are transforming patient care. Finally, it addresses the significant economic, regulatory, ethical, and social challenges impeding widespread adoption, including data privacy concerns, the risk of exacerbating health disparities, and the need for new frameworks to support this advanced medical paradigm.

Research done with the help of artificial intelligence, and presented by two AI-generated hosts.